GRP94-targeting antibody-interferon fusion molecule (Spectrum)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameGRP94-targeting antibody-interferon fusion molecule (Spectrum)
Drug Alias NameGRP94-targeting antibody-interferon fusion molecule (ImmunGene)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionHeat Shock Protein 90 Beta Family Member 1 modulatorsInterferon alpha ligand
TargetsHeat Shock Protein 90 Beta Family Member 1Interferon alpha
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmungene Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmungene IncSpectrum Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A